ArticleScientific reports2025
Evaluating the clinical utility of multimodal large language models in rare maculopathy.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Benchmark evaluation of multi-modal large language models for ophthalmic diagnosis in real world.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
This study aimed to assess how multimodal large language models (MLLM) diagnose and differentiate Pentosan Polysulfate (PPS) Maculopathy from other phenotypic mimics. A retrospective review of clinical records and multimodal retinal imaging was conducted with patients from the Shiley Eye Institute and Casey Eye Institute. Four MLLMs (ChatGPT-4o, Claude 3.5 Sonnet, Google Gemini 1.5 Pro, Perplexity Llama 3.1 Sonar/Default) along with human retinal specialists answered prompts based on retinal imaging and demographic data. Performance was evaluated using accuracy, sensitivity and specificity estimates. The study included 126 eyes from 63 patients, with 36 eyes with PPS maculopathy, 50 eyes with Stargardt disease, and 40 eyes with PRPH2-associated multifocal pattern dystrophy. MLLMs showed improved accuracy and sensitivity when answer choices were restricted, with ChatGPT consistently performing best when all imaging modalities were prompted together. The inclusion of demographic data further enhanced performance in prompts with limited answer choices. Human retinal specialist evaluations aligned with MLLM performance trends and also improved with demographic data. While MLLMs show diagnostic potential, further refinement is needed before clinical implementation. These findings highlight the importance of prompt design and demographic data to optimize MLLM performance with retinal imaging modalities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.